Brooks is supporting pathways that increase running access and participation for youth SEATTLE–(BUSINESS WIRE)–Today Brooks Running launched Future Run, an initiative to champion youth and help them discover the lifelong benefits of the run and its community. An evolution of the brand’s current community impact work, Future Run aims to reach 1 million young runners … [Read more…]
Analysts predict the hearing aid market to approach $6 billion by 2029 LA JOLLA, Calif.–(BUSINESS WIRE)–Hearing at Home LLC, a leading direct-to-consumer provider of cost-effective, reliable hearing aids, (formerly Nano Technologies LLC), announces the appointment of successful corporate growth driver David G. Burke as Chief Executive Officer and director. “As he has done with other … [Read more…]
BOISE, Idaho–(BUSINESS WIRE)–Albertsons Companies, Inc. (NYSE: ACI) announced today that it has partnered with global financial services technology leader FIS, which represents supplemental health benefits administrators including Fresh Connect, PayForward and WEX™ that utilize its technology payment platform. Additionally, Albertsons Cos. is entering into a partnership to accept benefit cards from Soda Health, which works … [Read more…]
Faster, Even Easier to Use — and 99.99% Inactivation of Candida auris and C.difficile Spores SAN ANTONIO–(BUSINESS WIRE)–This week at the Association for Perioperative Registered Nurses (AORN) Global Surgical Conference and Expo 2023, UltraViolet Devices, Inc. (UVDI) will showcase the new UVDI-360 Room Sanitizer — now equipped with UV Smart Connect™ cloud communications technology — … [Read more…]
– Taletrectinib, a potent, next-generation ROS1 TKI, continued to demonstrate clinically meaningful efficacy outcomes and favorable safety profiles in patients with ROS1 TKI-naïve or crizotinib-pretreated ROS1+ NSCLC. NEW YORK–(BUSINESS WIRE)–#BTD—AnHeart Therapeutics (“AnHeart”), a clinical-stage global biopharmaceutical company developing novel precision oncology therapeutics, announced today updated efficacy and safety data from a regional Phase 2 clinical … [Read more…]
TORONTO–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has successfully completed the optimization of a new extraction … [Read more…]
LONDON, Ontario–(BUSINESS WIRE)–Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the year ended December 31, 2022 pre-market on Tuesday, April 18, 2023. CONFERENCE CALL – Tuesday, April 18, 2023 at 8:30 a.m. (EDT): The Company will host a conference call … [Read more…]
Affirming 2023 guidance – introducing year-end medical margin guidance Anticipates reaching Adjusted EBITDA positive in early 2024 Management to Host Conference Call and Webcast March 31, 2023 at 8:30 AM ET HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial … [Read more…]
– The proof-of-concept open-label study evaluated the safety and tolerability, regulatory T cell (Treg) function, blood biomarkers, and preliminary efficacy of COYA 301 in eight patients with mild-to-moderate AD. The academic study was conducted by Dr. Appel and Dr. Faridar at the Houston Methodist Hospital. – COYA 301 is Coya’s investigational low-dose interleukin-2 (IL-2) for … [Read more…]
Q2’23 revenue increased approximately 17% quarter-over-quarter to $11.3 million, and approximately 466% year-over-year; Mednow patient count increased quarter over quarter, growing by more than 9% to ~38,000 in Q2’23 versus ~35,000 in Q1’23; Adjusted EBITDA improved 32% Y/Y; Cash flow from operations improved by 7% Q/Q; achieved additional cost savings post-Q2’23 to further reduce cash … [Read more…]
